Reaction Details |
| Report a problem with these data |
Target | D(2) dopamine receptor |
---|
Ligand | BDBM50048803 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_60217 (CHEMBL672179) |
---|
Ki | 2.8±n/a nM |
---|
Citation | Rowley, M; Bristow, LJ; Hutson, PH Current and novel approaches to the drug treatment of schizophrenia. J Med Chem44:477-501 (2001) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
D(2) dopamine receptor |
---|
Name: | D(2) dopamine receptor |
Synonyms: | D(2) dopamine receptor | DOPAMINE D2 | DOPAMINE D2 Long | DOPAMINE D2 Short | DRD2 | DRD2_HUMAN | Dopamine D2 receptor | Dopamine D2 receptor (D2) | Dopamine D2 receptor (D2R) | Dopamine D2A | Dopamine2-like | d2 |
Type: | Cell-surface receptors |
Mol. Mass.: | 50647.10 |
Organism: | Homo sapiens (Human) |
Description: | P14416 |
Residue: | 443 |
Sequence: | MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVS
REKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTA
SILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQN
ECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPL
KGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPP
SHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSR
RKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSA
VNPIIYTTFNIEFRKAFLKILHC
|
|
|
BDBM50048803 |
---|
n/a |
---|
Name | BDBM50048803 |
Synonyms: | 5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one | 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one | 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone) | 5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole) | CHEMBL708 | GEODON | ZIPRASIDONE | ZIPRASIDONE HYDROCHLORIDE |
Type | Small organic molecule |
Emp. Form. | C21H21ClN4OS |
Mol. Mass. | 412.936 |
SMILES | Clc1cc2NC(=O)Cc2cc1CCN1CCN(CC1)c1nsc2ccccc12 |
Structure |
|